One in three American adults has fatty liver disease. Most have no idea. Standard lab tests weren't designed to find it early — and that gap is costing lives.
A free consumer guide to fatty liver, hidden risk, and the evidence-backed path to reversal. Six sections. Peer-reviewed science. Yours free.
No spam. Unsubscribe anytime.
The liver is not just a detox organ. It sits at the center of your metabolic, cardiovascular, and hormonal health — and when it accumulates fat, the consequences reach far beyond the liver itself.
The liver regulates lipid metabolism, insulin signaling, and inflammatory pathways that directly drive cardiovascular risk. A fatty liver is a stressed liver — and that stress reaches your heart.
Glucose regulation, fat storage, and hormonal clearance all route through the liver. When overloaded with fat, these systems begin to misfire — often silently, for years.
Fatty liver rarely causes symptoms in its early stages. Most people have no idea. By the time symptoms appear, the reversal window may have passed.
higher all-cause mortality in patients with fatty liver vs. the general population
Issa et al. · J Hepatol 2025 · n=13,099
increased cardiovascular event risk across 52 studies and diverse global populations
Zhong et al. · AJPC 2026 · 52-study meta-analysis
of confirmed cases show completely normal liver enzymes — missed by standard screening
NASH Clinical Research Network
Average biomarker differences in patients with fatty liver vs. non-steatotic comparators. Each shift is subclinical individually — together they signal significant systemic strain. Source: Zhong et al., AJPC 2026.
ALT and AST measure liver cell damage — not fat accumulation. Research shows that 30–40% of people with confirmed fatty liver have completely normal enzyme values. A normal result is not the same as a healthy liver.
Elastography and ultrasound are designed to detect fibrosis and advanced structural change. Their sensitivity decreases significantly at early steatosis — precisely the stage where reversal is most achievable.
Fatty liver doesn't announce itself with one abnormal value. It builds silently through shifts in triglycerides, insulin resistance, inflammation markers, and liver function — each subclinical alone, but significant in combination.
Our free assessment reviews factors most associated with fatty liver in the research literature. No personal health data is stored. No clinical conclusions are drawn — just a clearer picture of where you stand, and what to do next.
Takes about 2 minutes
When identified in the right window and addressed across root-cause systems, fatty liver can be meaningfully reversed. The key is a complete picture — not a partial one.
Reversal begins with understanding which systems are under strain. Metabolic markers, inflammatory signals, insulin function, and liver-specific indicators together reveal what single tests cannot.
Dietary change, targeted movement, and metabolic support work at the system level. The liver responds rapidly to the right interventions when applied early enough.
Practitioners trained in comprehensive cardiometabolic assessment are equipped to evaluate your full risk profile and design a reversal-oriented approach tailored to your biology.
Reversal is measurable. The same multi-system assessment that identifies risk can confirm improvement — giving you and your practitioner a clear signal that the intervention is working.
"It is important that we do not only focus on the liver when treating patients with fatty liver disease. A holistic approach and early intervention involving different medical specialities can be crucial to improve the prognosis."
— Issa G, Shang Y, Strandberg R, Hagström H, Wester A · Journal of Hepatology · 2025;83:643–651
Practitioners listed here have completed advanced cardiometabolic training through the CMiQCertified program. This directory does not represent the exclusive approach to fatty liver management.